Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
about
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
@en
type
label
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
@en
prefLabel
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
@en
P17
P1050
P1476
A Multicenter, Randomized, Dou ...... in Subjects With Schizophrenia
@en
P3098
NCT00086593
P4844
P580
2004-05-01T00:00:00Z
P582
2005-07-01T00:00:00Z